ChatAbout Dr. Sainath Bhethanabhotla
- Dr. Sainath Bhethanabhotla is a talented and eminent Medical Oncologist.
- He has an experience of more than 10 years.
- His key areas of interest include Hodgkin lymphoma, especially in the pediatric and neonatal patient population.
- Dr. Sainath completed MBBS from Osmania Medical College, and his MD in Pediatrics from All India Institute of Medical Sciences.
- He also did a DM in Medical Oncology from All India Institute of Medical Sciences.
- He has various national and international publications under his name.
Hospital
Hospital Star Hospital, Financial District
Location
LocationHyderabad, India
Special Interest
Hodgkin lymphoma, especially in the pediatric and neonatal patient population.
List Of Treatments
- Metastatic Tumors Treatment
- Chemotherapy
- Radiotherapy
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Bile Duct Cancer Treatment
- Bladder Cancer Treatment
- Bone Cancer Treatment
- Breast Cancer-Surgical
- Cancer in Children
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Esophagus Cancer Treatment
- Ewing Family of Tumors Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Carcinoid Tumors Treatment
- Gastrointestinal Stromal Tumor GIST Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Kaposi Sarcoma Treatment
- Kidney Cancer Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Acute Lymphocytic Leukemia - ALL in Adults
- Leukemia in Children
- Liver Cancer
- Lung Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Small-cell Carcinoma Treatment
- Lung Carcinoid Tumor Treatment
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Nasal Cavity and Paranasal Sinus Cancer Treatment
- Nasopharyngeal Cancer Treatment
- Neuroblastoma
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Oral Cavity and Oropharyngeal Cancer
- Osteosarcoma (OS) Treatment
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Salivary Gland Cancer
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Basal Cell and Squamous Cell Carcinoma
- Skin Cancer - Melanoma
- Small Intestine Cancer Treatment
- Stomach Cancer Treatment
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Waldenstrom Macroglobulinemia
- Wilms Tumor (Nephroblastoma)
- Breast Biopsy
- Pediatric Bone Marrow Transplant
- Oral Cancer - Surgical
- Breast Cancer
- Leukemia Treatment
- Hairy Cell Leukemia - HCL
- Fallopian Tube Cancer
- Ovarian Germ Cell Tumor
- Ovarian Primary Peritoneal Cancer
- Medullary Carcinoma
- Papillary Thyroid Cancer Treatment
- Bone Marrow Cancer
- Ovarian Sex Cord Stromal Tumor
- Invasive Lobular Carcinoma
- Colon Cancer Treatment
- Cancer Treatment
- Adenocarcinoma - Glandular Cancer Treatment
- Immunotherapy
- Transarterial Chemoembolization - TACE
- Breast Conservation Surgery - BCS
- Breast Lumpectomy
- IMRT
- HIPEC
- Parathyroidectomy
- Lobectomy
- Completion Thyroidectomy
Work Experience of Dr. Sainath Bhethanabhotla
Consultant, Care Hospitals, Banjara Hills, Hyderabad
Consultant, Krishna Institute of Medical Sciences
Senior Resident, MNJ Institute of Oncology and Regional Cancer Center, Hyderabad
Senior Resident, All India Institute of Medical Sciences, New Delhi
Dr. Sainath Bhethanabhotla's
- MBBS, Osmania Medical College
- MD, All India Institute of Medical Sciences
- DM, All India Institute of Medical Sciences
1. Won Sorel Catherine Prize For Best Post Graduate in Pediatrics For The Year 2012. 2. Stood 2nd in NNF Gold Medal Paper For The Year 2012(1). 3. Received Scholarship For Oral Presentation in SIOP-2015, Cape Town, South Africa For The Abstract “OUTCOME OF PEDIATRIC HODGKIN LYMPHOMA TREATED WITH ABVD: A MULTICENTRIC ANALYSIS OF 335 PATIENTS”. 4. Awarded “Abstract Achievement Award” at American Society of Hematology Meeting on Hematological Malignancies Held in Chicago on 16th,17th September ,2016 For The Abstract “Prognostic Significance of Neutrophil-Lymphocyte Ratio in Advanced Pediatric Hodgkin Lymphoma-A Multicentric Analysis of 186 Patients”
- Bhethanabhotla S, Bakhshi S. Reply: Neither Post-Treatment PET-CT Nor Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma. J Nucl Med. 2016 Dec8;IMPACT FACTOR: 7.439
- Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, Et Al. Outcome Of Pediatric Advanced Hodgkin Lymphoma Treated With ABVD And Predictors Of Inferior Survival: A Multicenter Study Of 186 Patients. Leuk Lymphoma. 2016 Dec 6;1–7. IMPACT FACTOR:2.644
- Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, Et Al. Post- Treatment PET-CT Rather Than Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET-CT Versus Conventional Imaging. J Nucl Med. 2016 Oct 6; IMPACT FACTOR: 7.439
- Bhethanabhotla S, Bakhshi S. Presence Of Risk Factors Does Not Affect Outcome In Early Stage Pediatric Hodgkin Lymphoma Treated With ABVD. Ann Hematol. 2016 Nov 18; IMPACT FACTOR: 2.845
- Taywade SK, Kumar R, Bhethanabhotla S, Bal C. Role Of (18)F-FDG PET-CT In Monitoring The Cyclophosphamide Induced Pulmonary Toxicity In Patients With Breast Cancer - 2 Case Reports. Nucl Med Mol Imaging. 2016 Sep;50(3):261–5.
- Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D, Gogia A, Et Al. Primary Diffuse Large B-Cell Lymphoma Of The Prostate: A Report Of Two Cases With Diagnostic Considerations. J Cancer Res Ther. 2015 Dec;11(4):977–9. IMPACT FACTOR: 0.8459
- Gajendra S, Gogia A, Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Et Al. Synchronous Metastatic Pulmonary Adenocarcinoma With Small Cell Lymphoma. Leuk Lymphoma. 2014 Jul;55(7):1678–80. IMPACT FACTOR: 2.644
- Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Effect Of Position Of Infant During Phototherapy In Management Of Hyperbilirubinemia In Late Preterm And Term Neonates: A Randomized Controlled Trial. J Perinatol. 2013 Oct;33(10):795–9. IMPACT FACTOR: 2.183
- Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Et Al. Autologous Stem Cell Transplantation For Multiple Myeloma: Long-Term Results. The National Medical Journal Of India. 2016 Jul 1;29(4):192. IMPACT FACTOR: 0.786
- Bhethanabhotla, S., Tiwari, A., Sharma, M.C. Et Al. Prognostic Significance Of IL-6 In Hodgkin Lymphoma. Indian J Pediatr. 2019 Mar 4;Online First. IMPACT FACTOR: 1.046
- Patel A, Tannock I, Bhethanabhola S, Srivastva P, Biswas B, Et Al. Low-Dose Abiraterone In Metastatic Prostate Cancer: Is It Practice Changing? Facts And Facets.JCO Glob Oncol. 2020 Mar;6:382-386. IMPACT FACTOR:1.79
Wondering where to start?
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Dr. Sainath Bhethanabhotla in Hyderabad
Dr. S.V.S.S Prasad
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
39 years of experience
Apollo Hospitals, Jubilee Hills Hyderabad
Dr. Srinivas Chakravarthy Gummaraju
Medical Oncologist
Director
Fellowship,MBBS,MD
Hyderabad, India
19 years of experience
Apollo Hospitals, Jubilee Hills Hyderabad
Dr. Vijay Anand Reddy
Medical Oncologist
Director
DNB,Fellowship,MD
Hyderabad, India
30 years of experience
Apollo Hospitals, Jubilee Hills Hyderabad
Dr. A. V. S. Suresh
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
12 years of experience
Continental Hospitals, Hyderabad
Dr. Ravi Kumar
Medical Oncologist
Consultant
DNB,MBBS
Hyderabad, India
12 years of experience
Gleneagles Global Hospital, Lakdikapul, Hyderabad
Dr Saadvik Raghuram
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
7 years of experience
Medicover Hospital, Hitec City
Dr. Harish Kancharla
Medical Oncologist
Consultant
DM,MBBS,MD
Hyderabad, India
9 years of experience
